Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$252,680
-$26,060 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,776
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $10,194,826 across 8 Drug Manufacturers - General names. GILD ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
548,700 | $7,429,398 | |
| 2 | PFE |
Pfizer Inc
|
25,000 | $602,000 | |
| 3 | GRFS |
Grifols SA
|
77,728 | $550,314 | |
| 4 | LLY |
ELI LILLY & Co
|
350 | $419,800 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,700 | $346,950 | |
| 6 | ABBV |
AbbVie Inc.
|
1,350 | $339,714 | |
| 7 | JNJ |
Johnson & Johnson
|
1,000 | $253,970 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,000 | $252,680 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,680 | 2,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $278,740 | 2,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $245,480 | 2,000 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||